Cormorant Asset Management

Cormorant Asset Management as of Sept. 30, 2019

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 71 positions in its portfolio as reported in the September 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Mirati Therapeutics 11.1 $183M 2.4M 77.91
Turning Point Therapeutics I 8.1 $133M 3.5M 37.60
Spdr S&p 500 Etf (SPY) 7.2 $119M 400k 296.77
Biohaven Pharmaceutical Holding 4.8 $79M 1.9M 41.72
Apellis Pharmaceuticals (APLS) 4.4 $72M 3.0M 24.09
Ascendis Pharma A S (ASND) 4.2 $69M 718k 96.32
Reata Pharmaceuticals Inc Cl A 4.0 $66M 820k 80.29
Bridgebio Pharma (BBIO) 3.4 $56M 2.6M 21.47
Crispr Therapeutics (CRSP) 2.7 $44M 1.1M 40.99
Stoke Therapeutics (STOK) 2.3 $38M 1.8M 21.49
Principia Biopharma 2.3 $38M 1.3M 28.24
Blueprint Medicines (BPMC) 2.2 $36M 493k 73.47
Uniqure Nv (QURE) 2.2 $35M 900k 39.36
Allakos (ALLK) 2.1 $35M 444k 78.63
Tricida 2.0 $33M 1.1M 30.87
Axonics Modulation Technolog (AXNX) 2.0 $33M 1.2M 26.92
SPDR S&P Biotech (XBI) 1.9 $31M 400k 76.25
Quotient 1.7 $28M 3.6M 7.77
Nextcure (NXTC) 1.7 $27M 885k 30.85
Deciphera Pharmaceuticals 1.6 $27M 789k 33.94
Rocket Pharmaceuticals (RCKT) 1.5 $25M 2.1M 11.65
Myokardia 1.4 $23M 443k 52.15
Y Mabs Therapeutics (YMAB) 1.4 $23M 884k 26.06
Galapagos Nv- (GLPG) 1.4 $23M 150k 152.36
Anaptysbio Inc Common (ANAB) 1.3 $21M 591k 34.99
Amarin Corporation (AMRN) 1.2 $20M 1.3M 15.16
Eidos Therapeutics 1.2 $19M 541k 35.97
Kura Oncology (KURA) 1.1 $19M 1.2M 15.17
Akero Therapeutics (AKRO) 1.0 $17M 741k 22.75
Sarepta Therapeutics (SRPT) 1.0 $17M 222k 75.32
Twist Bioscience Corp (TWST) 1.0 $16M 687k 23.88
Argenx Se (ARGX) 0.9 $15M 128k 113.96
Nektar Therapeutics (NKTR) 0.9 $14M 789k 18.22
Satsuma Pharmaceuticals Ord 0.8 $13M 858k 15.01
Sage Therapeutics (SAGE) 0.8 $12M 89k 140.29
Chemocentryx 0.8 $12M 1.8M 6.78
Health Sciences Acqustn Corp unit 04/01/2024 0.7 $12M 1.1M 10.73
X4 Pharmaceuticals (XFOR) 0.7 $11M 882k 12.71
Inspire Med Sys (INSP) 0.6 $11M 172k 61.02
Gossamer Bio (GOSS) 0.6 $10M 618k 16.79
Eiger Biopharmaceuticals 0.6 $10M 998k 10.25
Zai Lab (ZLAB) 0.6 $9.0M 277k 32.35
Harpoon Therapeutics 0.5 $8.9M 650k 13.66
Avrobio Ord (AVRO) 0.5 $8.0M 568k 14.12
Orchard Therapeutics Plc ads 0.5 $8.0M 675k 11.88
Arena Pharmaceuticals 0.5 $7.9M 172k 45.77
Constellation Pharmceticls I 0.5 $7.8M 1.2M 6.46
Ra Pharmaceuticals 0.4 $7.0M 296k 23.65
Autolus Therapeutics Plc spon ads (AUTL) 0.4 $6.0M 480k 12.42
Genfit S A ads (GNFT) 0.3 $5.2M 300k 17.41
Atreca Inc Cl A (BCEL) 0.3 $5.0M 406k 12.24
Minerva Neurosciences 0.3 $4.7M 608k 7.75
Homology Medicines 0.3 $4.4M 245k 18.10
Atara Biotherapeutics 0.3 $4.2M 300k 14.12
Precision Biosciences Ord 0.2 $3.9M 468k 8.39
Rubius Therapeutics 0.2 $3.9M 492k 7.85
Neurocrine Biosciences (NBIX) 0.2 $3.5M 39k 90.10
Phasebio Pharmaceuticals 0.2 $3.4M 816k 4.17
Kezar Life Sciences (KZR) 0.2 $3.0M 928k 3.28
Igm Biosciences (IGMS) 0.2 $2.8M 156k 17.75
Iterum Therapeutics 0.1 $2.3M 396k 5.90
Adverum Biotechnologies 0.1 $1.6M 300k 5.45
Audentes Therapeutics 0.1 $1.4M 50k 28.10
Acceleron Pharma 0.1 $988k 25k 39.52
G1 Therapeutics 0.1 $1.0M 1.0k 1025.00
Scholar Rock Hldg Corp (SRRK) 0.1 $1.1M 119k 8.95
Inflarx Nv (IFRX) 0.1 $741k 300k 2.47
Abeona Therapeutics 0.0 $452k 200k 2.26
Aclaris Therapeutics (ACRS) 0.0 $270k 250k 1.08
Outlook Therapeutics Inc *w exp 02/18/201 0.0 $50k 417k 0.12
Outlook Therapeutics 0.0 $23k 16k 1.46